@article{20dd8b5e50e04713a1e1994b32dd92b9,
title = "Single-dose radical cure of Plasmodium vivax: A step closer",
abstract = "[No abstract available]",
keywords = "chloroquine, glucose 6 phosphate dehydrogenase, placebo, primaquine, tafenoquine, hemoglobin, antimalarial activity, drug dose comparison, drug efficacy, drug elimination, drug half life, drug megadose, drug treatment failure, enzyme activity, follow up, geographic distribution, glucose 6 phosphate dehydrogenase deficiency, hemolysis, host resistance, human, latent period, low drug dose, medication compliance, monotherapy, multicenter study (topic), nonhuman, note, parasite clearance, phase 2 clinical trial (topic), phase 3 clinical trial (topic), Plasmodium vivax, Plasmodium vivax malaria, priority journal, randomized controlled trial (topic), recurrent infection, reinfection, relapse, rodent malaria, single drug dose, treatment duration, anemia, developmental disorder, double blind procedure, drug tolerability, elimination half-life, hemoglobin blood level, malnutrition, morbidity, Note, Plasmodium falciparum, practice guideline, spontaneous abortion, Aminoquinolines, Antimalarials, Chloroquine, Female, Humans, Malaria, Vivax, Male",
author = "Price, {Ric N.} and Francois Nosten",
year = "2014",
month = mar,
day = "22",
doi = "10.1016/S0140-6736(13)62672-0",
language = "English",
volume = "383",
pages = "1020--1021",
journal = "Lancet",
issn = "0140-6736",
publisher = "The Lancet Publishing Group",
number = "9922",
}
